Luis M. Vilá to Hydroxychloroquine
This is a "connection" page, showing publications Luis M. Vilá has written about Hydroxychloroquine.
Connection Strength
1.413
-
V?zquez-Otero I, Medina-Cintr?n N, Arroyo-?vila M, Gonz?lez-Sep?lveda L, Vil? LM. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus. Lupus Sci Med. 2020 05; 7(1).
Score: 0.656
-
Jolly M, Sehgal V, Arora S, Azizoddin D, Pinto B, Sharma A, Devilliers H, Inoue M, Toloza S, Bertoli A, Blazevic I, Vil? LM, Moldovan I, Torralba KD, Mazzoni D, Cicognani E, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Clarke A, Weisman M, Wallace D, Mok CC. Does hydroxychloroquine improve patient reported outcomes in patients with lupus? Lupus. 2021 Oct; 30(11):1790-1798.
Score: 0.179
-
Arroyo-?vila M, Vil? LM. Cardiac tamponade in a patient with mixed connective tissue disease. J Clin Rheumatol. 2015 Jan; 21(1):42-5.
Score: 0.113
-
Willis R, Seif AM, McGwin G, Martinez-Martinez LA, Gonz?lez EB, Dang N, Papalardo E, Liu J, Vil? LM, Reveille JD, Alarc?n GS, Pierangeli SS. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus. 2012 Jul; 21(8):830-5.
Score: 0.093
-
Pons-Estel GJ, Alarc?n GS, Gonz?lez LA, Zhang J, Vil? LM, Reveille JD, McGwin G. Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort. Arthritis Care Res (Hoboken). 2010 Mar; 62(3):393-400.
Score: 0.081
-
Pons-Estel GJ, Alarc?n GS, McGwin G, Danila MI, Zhang J, Bastian HM, Reveille JD, Vil? LM. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum. 2009 Jun 15; 61(6):830-9.
Score: 0.077
-
Alarc?n GS, McGwin G, Bertoli AM, Fessler BJ, Calvo-Al?n J, Bastian HM, Vil? LM, Reveille JD. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis. 2007 Sep; 66(9):1168-72.
Score: 0.066
-
Fern?ndez M, McGwin G, Bertoli AM, Calvo-Al?n J, Vil? LM, Reveille JD, Alarc?n GS. Discontinuation rate and factors predictive of the use of hydroxychloroquine in LUMINA, a multiethnic US cohort (LUMINA XL). Lupus. 2006; 15(10):700-4.
Score: 0.061
-
Fessler BJ, Alarc?n GS, McGwin G, Roseman J, Bastian HM, Friedman AW, Baethge BA, Vil? L, Reveille JD. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum. 2005 May; 52(5):1473-80.
Score: 0.058
-
Calvo-Al?n J, McGwin G, Toloza S, Fern?ndez M, Roseman JM, Bastian HM, Cepeda EJ, Gonz?lez EB, Baethge BA, Fessler BJ, Vil? LM, Reveille JD, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study. Ann Rheum Dis. 2006 Jun; 65(6):785-90.
Score: 0.015
-
Ho KT, Ahn CW, Alarc?n GS, Baethge BA, Tan FK, Roseman J, Bastian HM, Fessler BJ, McGwin G, Vil? LM, Calvo-Al?n J, Reveille JD. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events. Rheumatology (Oxford). 2005 Oct; 44(10):1303-7.
Score: 0.015